CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in SRRK — Scholar Rock Holding Corp
CIK 884546
SAN FRANCISCO, CA
Position in SRRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$47,535,730
+$13,074,030 QoQ
Shares Held
864,286
+23.3% QoQ
Ownership
0.710%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#36
of 304 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. SRRK ranks #37 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in SRRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,535,730 | 864,286 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $34,461,700 | 701,011 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $30,927,284 | 702,095 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $25,212,783 | 677,035 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $22,523,259 | 635,891 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $19,839,990 | 617,107 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $26,900,516 | 622,409 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,027,371 | 502,793 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,837,247 | 460,654 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,148,062 | 402,481 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $7,409,794 | 394,138 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,146,926 | 302,384 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,915,175 | 254,002 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,443,520 | 180,440 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,659,127 | 183,329 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,253,782 | 180,921 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $647,122 | 117,873 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,572,212 | 199,551 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,821,468 | 194,101 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,105,001 | 184,888 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,919,942 | 66,434 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,157,840 | 62,334 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,965,716 | 61,111 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $906,241 | 51,229 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $977,257 | 53,666 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $542,249 | 44,777 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||